Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Here's the bad news.

EPS is all that matters. What is that $23M in cash worth? 4 cents a share?

No licensing fees, no EPS. No EPS, no multiple.





Share
New Message
Please login to post a reply